Antagonistic <i>in vitro</i> interaction between olorofim and voriconazole against <i>Aspergillus fumigatus</i>
These findings demonstrate the in vitro antagonism between olorofim and voriconazole and underscore the need for further investigation before considering their combined clinical use.
Authors
- Éric Dannaoui (ORCID: https://orcid.org/0000-0002-2817-3830)
- Patrick Schwarz (ORCID: https://orcid.org/0000-0003-0383-1865)
- Marie‐Elisabeth Bougnoux (ORCID: https://orcid.org/0000-0003-4721-2740)
- Anne-Laure Bidaud
- Illan Laloum (ORCID: https://orcid.org/0009-0007-8139-8557)
- Elise Recalt (ORCID: https://orcid.org/0009-0007-8478-2124)
Institutions
- Goethe University Frankfurt (DE)
- Université Paris-Est Créteil (FR)
- Université Paris Cité (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Institut de Myologie (FR)
- University Hospital Frankfurt (DE)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-10-14
- DOI
- https://doi.org/10.1093/jac/dkaf393
- Citations
- 2
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 2.79